May 15, 2024
ASHBi will hold the ASHBi SignAC Workshop: High-content epigenome analysis in the next phase on 15 May 2024
The epigenomic state of individual cells is controlled across multiple dimensions, and elucidating this state requires the integration of various analytical techniques. In this workshop, we will focus on remarkable advancements in such analytical techniques, including long-range genomic DNA molecule analysis, spatial analysis techniques, and temporal change analysis techniques, inviting leading researchers from both domestic and international fields to lecture. We will then discuss the prospects for the future integration of these analytical techniques.
13:00-13:05 |
13:05-14:00 | Ana Conesa (Spanish National Research Council) Long-read sequencing to study the transcriptome and epigenome |
14:00–14:30 | Ayako Suzuki (Univ. Tokyo) Long-read sequencing and phasing analysis for revealing aberrant epigenome statuses in lung cancer genomes |
14:30–15:00 | Break |
15:00–15:30 | Seitaro Nomura (Univ. Tokyo) Single-cell and spatial omics analysis to dissect the biology of cardiovascular disease |
15:30–16:00 | Mizuki Honda (Kyoto Univ./Hiroshima Univ.) High-resolution and High-depth Spatial Transcriptomics Based on Microstructure |
16:00–16:30 | Kazunori Sunadome (Kyoto Univ.) Cell fate profiling in 3D tissue with whole-mount in situ sequencing |
16:30–17:00 | Break |
17:00–17:30 | Toshiaki Yachimura (Tohoku Univ.) Reconstruction of Developmental Dynamics through the Lens of Optimal Transport |
17:30-18:25 | Winston Timp (Johns Hopkins University) TBA |
18:25-18:30 |
18:30-20:00 | Networking and Discussion [NOTE] Participation Fee: 2,000 JPY (General) / Free (students) * Fees will be collected on the event day by cash in Japanese Yen [NOTE] Please register using the registration form. [NOTE] If you need to cancel your registration after you have registered, please contact us by May 8. |
Registered participants only Registration Form (Google Form)
(Registration deadline: 8 May 2024 / Number of participants: Limited to 200)
Taro Tsujimura, Takuya Yamamoto, Mitinori Saitou Institute for the Advanced Study of Human Biology (WPI-ASHBi)